Lymphoma, B-Cell Clinical Trials

A listing of Lymphoma, B-Cell medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Languages supported at study center
Age Group

Any (17)

Phase 1 (6)
Phase 1/2 (3)
Phase 2 (4)
Phase 3 (2)
Unknown (2)

Interventional (16)
Observational (1)

The First Affiliated Hospital with Nanjing Medical University (2)
Affiliated Hospital to Academy of Military Medical Sciences (1)
BeiGene (1)
Beijing InnoCare Pharma Tech Co., Ltd. (1)
Curon Biopharmaceutical (Australia) Co Pty Ltd (1)
Dana-Farber Cancer Institute (1)
Fate Therapeutics (1)
Fujian Medical University (1)
Henan Cancer Hospital (1)
Loyola University (1)
Memorial Sloan Kettering Cancer Center (1)
Merck Sharp & Dohme LLC (1)
Ruijin Hospital (1)
Seattle Genetics, Inc. (1)
Second Affiliated Hospital, School of Medicine, Zhejiang University (1)
Shenzhen Geno-Immune Medical Institute (1)

No (17)

No (17)

All Languages (1)

Adult (18+) (17)
Pediatric (Under 18) (2)

I am/have/had

I am/have/hadlymphoma

I am/have/hadb-cell lymphoma

I am/have/hadmeasurable disease

I am/have/haddiffuse large b-cell lymphoma

I am/have/hadcancer

I am/have/hadhodgkin's disease

I am/have/hadnon-hodgkin lymphoma

I am/have/hadfollicular lymphoma

I am/have/hadlarge b-cell lymphoma

I am/have/hadchronic lymphocytic leukemia

I am/have/hadmalt

I am/have/hadgilbert's syndrome

I am/have/hadmantle cell lymphoma

I am/have/hadleukemia

I am/have/hadmarginal zone lymphoma

I am/have/hadlymphocytic leukemia

I am/have/hadb-cell lymphoma refractory

I am/have/hadcell transplantation

I am/have/hadapheresis

I am/have/hadrefractory b-cell non-hodgkin lymphoma

added new label for I am/have/had

I am looking for

I am looking forrituximab

I am looking formonoclonal antibodies

I am looking forcyclophosphamide

I am looking foribrutinib

I am looking foravid

I am looking forvincristine

I am looking forfludarabine

I am looking fordoxorubicin

I am looking forprednisone

I am looking forbortezomib

I am looking fortositumomab

I am looking forbtk inhibitor

I am looking foranthracyclines

I am looking forobinutuzumab

I am looking forimmunosuppressive agents

I am looking forbrentuximab vedotin

I am looking forfilgrastim

I am looking fordirect bilirubin

I am looking foretoposide

I am looking forlenalidomide

added new label for I am looking for

Advanced Filters

Found 243 clinical trials

None

None views

For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

Lenalidomide in Combination With R-GemOx in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma

The purpose of this study is to investigate efficacy and safety of Lenalidomide in combination with R-GemOx as first-line treatment of elderly patients with Diffuse large B cell lymphoma.

lenalidomide

diffuse large b-cell lymphoma

gemox

hiv related lymphoma

b-cell lymphoma

0 views
16 Feb, 2024
1 location

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

CD19 CAR-T Expressing IL7 and CCL19 Combined With PD1 mAb for Relapsed or Refractory Diffuse Large B Cell Lymphoma

Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin's lymphoma, accounting for 35% of lymphoma. Chimeric antigen receptor T cell (CAR-T) therapy is a new method to treat DLBCL.

rituximab

remission

b-cell acute lymphoblastic leukemia

refractory b-cell non-hodgkin lymphoma

large b-cell lymphoma

0 views
05 Aug, 2020

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Safety of Autologous Humanized Anti-CD19 and Anti-CD20 Dual Specific CAR-T Cells in Adult Patients With Diffuse Large B-cell Lymphoma

This is a single-arm, open-label, dose escalation, phase I study, aiming to evaluate the safety and efficacy of Autologous Humanized Anti-CD19 and Anti-CD20 Dual Specific Chimeric Antigen Receptor (CAR) T-cells in patient with relapsed or refractory diffuse B cell lymphoma.

0 views
16 Feb, 2024
1 location